Skip to main content

UBS Group AG

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1610520 ZURICH, V8

Position in XFOR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$271,060
-$833,054 QoQ
Shares Held
58,043
-78.3% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 89 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. XFOR ranks #324 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XFOR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $271,060 58,043
2026-03-31 $1,104,114 267,340
2025-12-31 $16,516 4,129
2025-09-30 $546,635 159,835
2025-06-30 $208,921 109,959
2025-03-31 $1,188,774 5,037,183
2024-12-31 $677,525 923,060
2024-09-30 $174,692 261,126
2024-06-30 $35,976 62,030
2024-03-31 $179,425 129,084
2023-12-31 $1,027 1,225
2023-09-30 $155,576 142,731
2023-06-30 $4,897 2,525
2023-03-31 $86,999 100,000
2022-09-30 $16,287 9,525
2022-06-30 $1,172 1,215
2022-03-31 $2,210 1,263
2021-12-31 $1,529 668
2021-06-30 $792 122
2021-03-31 $34,353 3,990
2020-12-31 $99,163 15,422
2020-09-30 $75,478 11,149
2020-06-30 $47,513 5,098
2020-03-31 $92,829 9,283